NCT01466543View on ClinicalTrials.gov

Effect of Zydena (Udenafil) on Cerebral Blood Flow and Peripheral Blood Viscosity

PHASE2UnknownINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

March 31, 2012

Study Completion Date

November 30, 2012

Conditions
Vascular DementiaSubcortical Vascular Dementia
Interventions
DRUG

Zydena (Udenafil)

Zydena (Udenafil) 100 mg, one time

DRUG

Placebo

Placebo

Trial Locations (1)

135-710

Samsung Medical Center, Seoul

Sponsors
All Listed Sponsors
collaborator

Dong-A Pharmaceutical Co., Ltd.

INDUSTRY

lead

Samsung Medical Center

OTHER